Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Biohit Oyj OK'd to Start China Production of Cancer Screening Test

publication date: Oct 25, 2016
Biohit Oyj, a Finnish medical diagnostics company, reported that its China joint venture, Biohit HealthCare (Hefei), was granted a China production license for its GastroPanel® products. GastroPanel is a non-invasive test for low levels of acid in the stomach, a risk factor for gastric cancer. Low levels of stomach acid can be caused by H. pylori infection or dysfunction of the stomach mucosa (atrophic gastritis). The JV is 60% owned by China's Wisdom-Win. More details....

Stock Symbol: (HEL: BIOBV)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital